Upgrade to SI Premium - Free Trial

FDA approves Telix's Pixclara as first PET imaging drug for glioma

September 14, 2026 6:30 AM
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) announced that the U.S. Food and Drug Administration has approved its New Drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA